- Sacituzumab govitecan in the treatment of triple negative breast cancer2023 | First Faculty of Medicine
- Immunotherapy in the treatment of triple negative breast cancer2022 | First Faculty of Medicine
- Triple negative breast cancer2021 | First Faculty of Medicine
- Immunotherapy of triple negative breast cancer2019 | First Faculty of Medicine, Central Library of Charles University, Faculty of Physical Education and Sport
- Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group2023 | Faculty of Medicine in Pilsen
- Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness2023 | Second Faculty of Medicine, Faculty of Science
- Promising treatment options of triple negative breast cancer2017 | First Faculty of Medicine, Central Library of Charles University
- Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer2021 | Faculty of Medicine in Hradec Králové
- Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional studyPublication without faculty affiliation
- Morphological and gene-expression characterization of viable heterogeneous circulating tumor cells size-captured and cultured from triple-negative breast cancer mouse models +12016 | First Faculty of Medicine
- Revelation in the treatment of triple-negative breast cancers2020 | First Faculty of Medicine
- Treatment strategy of triple negative breast cancer in young women - do we treat them differently?2023 | First Faculty of Medicine
- Ixabepilone Alone or With Cetuximab as First-Line Treatment for Advanced/Metastatic Triple-Negative Breast Cancer2015 | Publication without faculty affiliation
- Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer2019 | First Faculty of Medicine
- Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report2016 | Faculty of Medicine in Hradec Králové
- Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade2020 | Second Faculty of Medicine
- Sacituzumab govitecan2022 | First Faculty of Medicine
- The toxic effect of cytostatics on primary cilia frequency and multiciliation2019 | Faculty of Medicine in Hradec Králové
- Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy2022 | Faculty of Medicine in Hradec Králové
- Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer - results from an international, multicenter analysis coordinated by the AGMT Study group2022 | Faculty of Medicine in Pilsen
- High frequency of complex TP53 mutations in CNS metastases from breast cancer2012 | Third Faculty of Medicine
- Therapeutic options in patients with early breast cancer2023 | First Faculty of Medicine
- A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)2021 | Publication without faculty affiliation
- NT5E CpG island methylation is a favourable breast cancer biomarker2012 | Third Faculty of Medicine
- EGFR in triple negative breast carcinoma: significance of protein expression and high gene copy number2015 | Faculty of Medicine in Hradec Králové
- Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses2014 | First Faculty of Medicine
- Hereditary breast cancer - an example of uncommon breast cancer in population2009 | First Faculty of Medicine
- Aktuální možnosti léčby metastazujícího triple negativního karcinomu prsu2022 | First Faculty of Medicine
- Predictive markers in breast cancer2021 | First Faculty of Medicine